NewsStackNewsStack
Daily Brief: Which companies are hyping vs delivering: red flags, real signals and repeat offenders, free daily.

NVRS

CSE:NVRSCSE
4 announcements
Credibility Score88%
Noveris Health Sciences Announces Commencement of Strategic Review Process
Weak Signaldeteriorating

Noveris faces urgent cash constraints and has launched a strategic review to seek options.

13 Nov 2026, 22:22 UTC
▼
Noveris Health Sciences Announces Proposed Private Placement of Convertible Debentures for up to $500,000
Routineunclear

Noveris seeks up to $500,000 via convertible debentures with 10% annual interest.

20 Aug 2026, 22:23 UTC
▼
Noveris Health Sciences Receives USPTO Notice of Allowance, and Signs Work Order with API
OverhypedModerate hypeunclear

Patent milestone reached, but commercial impact and research outcomes remain unproven.

18 Aug 2026, 21:11 UTC
▼
Noveris Health Sciences Joins BioAlberta
Routineunclear

Noveris joins BioAlberta, but no financial or operational impact is disclosed.

30 Jul 2026, 23:19 UTC
▼